Avibactam Sodium; Aztreonam Patent Expiration
Avibactam Sodium; Aztreonam was first introduced by Abbvie Inc
Avibactam Sodium; Aztreonam Patents
Given below is the list of patents protecting Avibactam Sodium; Aztreonam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Emblaveo | US8969566 | Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof | Jun 15, 2032 | Abbvie |
| Emblaveo | US9284314 | Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof | Jun 15, 2032 | Abbvie |
| Emblaveo | US9695122 | Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof | Jun 15, 2032 | Abbvie |
| Emblaveo | US8471025 | Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt | Aug 12, 2031 | Abbvie |
| Emblaveo | US8835455 | Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt | Oct 08, 2030 | Abbvie |
| Emblaveo | US7612087 | Heterocyclic compounds as inhibitors of beta-lactamases | Nov 12, 2026 | Abbvie |
| Emblaveo | US7112592 | Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents | Jan 07, 2026 | Abbvie |
Avibactam Sodium; Aztreonam's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List